Target intelligence / Profile preview

Mycobacterium tuberculosis cell envelope (Mtb cell envelope)

Target
Mtb cell envelope
Molecular classification
Cell wall, Complex biological structure, Lipid-rich envelope
01

Overview

The Mycobacterium tuberculosis cell envelope is a highly complex and unique multi-layered structure that serves as the primary interface between the bacterium and its host. It is characterized by a core mAGP complex consisting of peptidoglycan covalently linked to arabinogalactan, which is in turn esterified to long-chain mycolic acids (Dulberger et al., 2020, Nature Reviews Microbiology). This lipid-rich mycomembrane creates an exceptionally impermeable barrier that protects the pathogen from host immune effector mechanisms and many standard antibiotics (Brennan, 2003, Tuberculosis). Because several components of the envelope are unique to mycobacteria, they represent ideal targets for therapeutic intervention. Frontline drugs like isoniazid and ethambutol work by disrupting the synthesis of mycolic acids and arabinogalactan, respectively, leading to cell wall instability and bacterial death (Goude & Parish, 2008, Future Microbiology). The envelope also contains various glycolipids and proteins that modulate the host immune response, contributing significantly to the pathogenesis of tuberculosis (Jackson, 2014, Cold Spring Harbor Perspectives in Medicine). Furthermore, the envelope's dynamic nature allows the bacterium to adapt to different environments within the host, such as the acidic conditions of the phagosome (Marrakchi et al., 2014, Microbiology Spectrum).

Other names
Mycobacterium tuberculosis cell wallMycobacterial cell envelopemAGP complexAcid-fast cell wall
02

Mechanism of action

Inhibition of mycolic acid biosynthesis, inhibition of arabinogalactan synthesis, inhibition of peptidoglycan cross-linking, and disruption of the mycobacterial outer membrane integrity.

03

Biological functions

Physical barrierVirulence factorOsmotic protectionHost-pathogen interactionNutrient transport
04

Disease associations

TuberculosisInfection
05

Safety considerations

Development of multi-drug resistance (MDR-TB)Hepatotoxicity of associated drugsPoor drug penetration into caseous lesionsLong treatment duration requirements
06

Interacting drugs

Isoniazid

7 more in the full profile.

07

Biomarkers

Lipoarabinomannan (LAM)Mycolic acidsTrehalose dimycolate (TDM)

Beyond the preview

Go deeper on Mycobacterium tuberculosis cell envelope (Mtb cell envelope).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis cell envelope (Mtb cell envelope).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call